为您找到相关结果约243个

你是不是要搜索 期刊VTd 点击跳转

Daratumumab - VTD vs VTD: peri-transplant evaluation

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy comparedto four cycles of VTD for newly diagnosed multiple myeloma

VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory

A Matching-adjusted Indirect Comparison (MAIC) of Bortezomib-Thalidomide-Dexamethasone (VTd) and DaratumumabPlus VTd (D-VTd) Versus Bortezomib-Dexamethasone (Vd) in Patients with Newly Diagnosed Multiple Myeloma

A Matching-adjusted Indirect Comparison (MAIC) of Bortezomib-Thalidomide-Dexamethasone (VTd) and DaratumumabPlus VTd (D-VTd) Versus Bortezomib-Cyclophosphamide-Dexamethasone (VCd) in Patients (Pts) with Newly

Controllable orientations for Sb2S3 solar cells by vertical VTD method

Psychometric Characteristics of Different Versions of Vocal Tract Discomfort (VTD) Scale: A Systematic

Phase 3 randomized study of daratumumab (DARA) plus bortezomib/thalidomide/dexamethasone (D-VTd) vs VTd

Cross-cultural Adaptation and Validation of the Italian Version of the Vocal Tract Discomfort Scale (I-VTD

Improving the performance of Sb2S3 thin-film solar cells by optimization of VTD source-substrate proximity

Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible

Efficacy of intensive salvage regimen (VTD-PACE and DCEP regimen) in the era of novel agents

VTD EXPERIENCE AS AN INDUCTION TREATMENT TO TRANSPLANT IN PATIENTS WITH NEW DIAGNOSIS OF MULTIPLE MYELOMA

Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE

Lenalidomide Maintenance after VTD Induction and Autologous Stem Cell Transplantation: An Italian Real-Life

为您找到相关结果约243个

共243条页码: 1/17页15条/页